Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine

This publication has 35 references indexed in Scilit:

• Recent progress in pancreatic cancer
  CA: A Cancer Journal for Clinicians, 2013
• Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?
  Expert Review of Anticancer Therapy, 2013
• Mechanisms of chemoresistance in cancer stem cells
  Clinical and Translational Medicine, 2013
• Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression
  Journal of Cancer Research and Clinical Oncology, 2012
• Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
  Theranostics, 2012
• Adjuvant and neoadjuvant treatment in pancreatic cancer
  World Journal of Gastroenterology, 2012
• Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells
  Oncology Letters, 2011
• Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
  Annals of Oncology, 2009
• Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
  Nanomedicine, 2008
• Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery
  Biomaterials, 2007